Skip to main content
High RiskFDAfda-H-0214-2026UNDECLARED ALLERGEN

Meadow Gold Hawaii's Dairy Fat Free Chocolate Milk, Grade A Pasteurized Homogenized Vitamin A&D, half-pint carton. Product is perishable...

Category
Units Affected
75,566
Recall Date
October 14, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0214-2026.

Half-pint chocolate fat free milk is recalled due to potential quality control issues.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0214-2026.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Meadowgold Dairies Hawaii Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0214-2026.

Meadowgold Dairies Hawaii LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Meadowgold Dairies Hawaii Llc Recall FAQ

Meadowgold Dairies Hawaii Llc is the subject of a dairy safety report: Meadow Gold Hawaii's Dairy Fat Free Chocolate Milk, Grade A Pasteurized Homogenized Vitamin A&D, half-pint carton. Product is perishable.... The notice was published on October 14, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 75,566 units are potentially affected.